.Adhering to an inadequate presenting for Lykos Therapies' MDMA prospect for trauma at a recent FDA ...
.AN2 Rehabs is reassessing its company in response to poor midphase information, vowing to give up h...
.Merck & Co. is paying out $700 million upfront to test Amgen in a blood cancer market. The barga...
.Along With Gilead Sciences about to an FDA selection for its own liver disease medicine seladelpar,...
.Chief executive officer David Ricks may find the companies establishing outdoors tents at basecamp ...
.Mattress Liquidators has actually transformed Entero Rehabs white as a piece. The financial institu...
.Exelixis is giving up on its tissue aspect (TF)- targeting antibody-drug conjugate after concluding...
.3 full weeks after Roche's Genentech unit left an SHP2 inhibitor pact, Relay Therapy has validated ...
.Stoke Therapeutics' Dravet disorder medicine has actually been actually devoid of a predisposed hol...
.Tough Biotech Associate Editor Gabrielle Masson provided the 2024 course of Brutal 15 winners on th...